Tooth eruption problems

K11_ERUPTION

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — K00.68, K00.69, K01.0 Hospital discharge: ICD-10 — K00.68, K00.69, K01.0 Cause of death: ICD-10 — K00.68, K00.69, K01.0 3 out of 7 registries used, show all original rules.	6825
4. Check minimum number of events None	6825
5. Include endpoints None	6825
6. Filter based on genotype QC (FinnGen only)	6825

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF10

NAME	K11_ERUPTION
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	K010\|K0068\|K0069
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K010\|K0068\|K0069
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K010\|K0068\|K0069
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Tooth eruption problems based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Embedded teeth, including avohilmo

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	91279	51833	39146
Only index persons	83055	47728	35327
Unadjusted period prevalence (%)
Whole population	1.31	1.48	1.09
Only index persons	1.58	1.75	1.35
Median age at first event (years)
Whole population	18.48	19.71	16.75
Only index persons	19.80	20.92	18.28

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6825	4897	1928
Unadjusted period prevalence (%)	1.44	1.67	0.85
Median age at first event (years)	26.37	25.69	28.10

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5644: Matched controls
56052

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

3.2

323.0

3519

19034

K00.68

ICD-10 Finland

Other disturbance in the tooth eruption

+∞

323.0

1747

K00.69

ICD-10 Finland

Disorders in the tooth eruption UNS

+∞

323.0

528

K01.0

ICD-10 Finland

Embedded teeth

+∞

323.0

3532

EBA10

NOMESCO Finland

Surgical removal of tooth

6.7

323.0

2882

7537

EBA12

NOMESCO Finland

Complicated surgical removal of tooth

6.0

258.8

774

1435

EBA00

NOMESCO Finland

Extraction of tooth

2.6

243.3

2809

15474

K05.32

ICD-10 Finland

Periodontitis NOS

2.9

191.7

1416

5789

WX110

NOMESCO Finland

Local anesthesy

2.5

174.9

4503

34478

SAA01

NOMESCO Finland

Simple examination of mouth

2.5

168.1

4670

36687

WZA90

NOMESCO Finland

Other doctors statement

2.3

162.5

1949

10296

SAA03

NOMESCO Finland

Extended examination of mouth

2.1

154.8

3124

20741

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.1

142.1

2174

12657

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

3.9

140.5

645

1814

WX290

NOMESCO Finland

Other blockade of nerve

2.0

135.5

3433

24392

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.1

135.2

2251

13510

SAA02

NOMESCO Finland

Basic examination of mouth

2.1

114.7

4570

37383

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

4.3

110.7

446

1105

ECA00

NOMESCO Finland

Surgical exposure of tooth

12.2

95.0

177

148

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.3

64.3

652

2996

KMAK

NOMESCO Finland

1.6

61.7

2958

22887

Z01.2

ICD-10 Finland

Dental examination

1.6

60.5

2734

20795

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

60.3

2814

21569

EFA50

NOMESCO Finland

Excision of cyst of jaws

9.9

55.3

114

117

K09.03

ICD-10 Finland

Cyst eruption

16.2

53.2

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

53.2

2894

22728

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

4.9

52.5

179

373

EMAK

NOMESCO Finland

3.0

51.4

313

1070

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.3

51.3

527

2424

K00.7

ICD-10 Finland

Teething syndrome

2.2

48.4

510

2373

K02.1

ICD-10 Finland

Caries of dentine

1.5

47.3

3575

29861

K03.64

ICD-10 Finland

Dental calculus supragingival

1.5

45.8

1907

13904

WZA00

NOMESCO Finland

Short statement of of health and health related matters

2.3

43.5

445

2037

EDC10

NOMESCO Finland

Sagittal osteotomy of ramus of mandible

6.7

42.1

110

166

K05.22

ICD-10 Finland

Acute pericoronitis

1.9

41.2

709

4008

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

4.7

40.9

144

311

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.5

40.5

3511

29642

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

40.5

4057

35311

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

2.3

38.8

396

1808

K01.17

ICD-10 Finland

Retained molar with obstruction in the lower jaw

2.3

38.6

368

1624

127

Kela drug reimbursment

Transplant complication

5.2

38.3

123

241

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.5

37.3

1841

13782

SBB10

NOMESCO Finland

Teeth copy

1.8

37.2

745

4420

K07.13

ICD-10 Finland

Retrognaty, mandibular

3.4

36.3

185

557

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.1

35.9

456

2292

K01.1

ICD-10 Finland

Impacted teeth

3.8

33.0

144

383

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.9

32.8

520

2843

SJD10

NOMESCO Finland

Attachment of arrow to fixed orthodontisk device

2.0

32.5

428

2182

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.9

32.3

542

3023

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.4

32.3

282

1190

K07.35

ICD-10 Finland

Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth

3.9

32.0

135

348

-1

NOMESCO Finland

1.4

31.3

2387

19250

D82

ICPC

Teeth/gum disease

1.4

30.7

2165

17193

Z94.0

ICD-10 Finland

Kidney transplant status

5.4

30.6

172

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

30.5

3125

26481

SJD00

NOMESCO Finland

Removal or reattacment of arrow in fixed orthodontisk device

2.0

30.4

416

2149

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.9

29.7

466

2536

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.7

28.8

703

4399

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.5

28.6

1142

8080

SJC01

NOMESCO Finland

Positioning and fixed attachment of single bracket (Bracket with fixed attachment)

2.0

27.7

360

1823

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

27.6

313

1497

K01.12

ICD-10 Finland

Retained canine with obstruction in the upper jaw

6.3

26.9

114

L04AA06

ATC

mycophenolic acid; systemic

4.0

26.8

109

273

D19

ICPC

Teeth/gum symptom/complaint

1.4

26.7

1521

11537

SJD20

NOMESCO Finland

Attachment of modifiable arrow of fixed orthodontisk device

2.1

26.6

322

1586

SDA02

NOMESCO Finland

Parodonthologic therapy

1.4

26.1

1763

13779

L04AA01

ATC

[U] ciclosporin; systemic

5.1

26.0

163

SXC05

NOMESCO Finland

Other oral or dental procedure

1.7

25.7

531

3162

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.5

24.9

1013

7170

SJC10

NOMESCO Finland

Orthodontic bandage in one tooth

2.1

24.4

292

1430

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.4

24.2

1741

13717

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

24.2

3029

26042

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

24.0

1639

12796

SXC03

NOMESCO Finland

Other oral or dental procedure

4.9

23.9

162

K00.00

ICD-10 Finland

Hypodontia

2.8

23.7

158

575

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

23.5

1101

8009

K05.30

ICD-10 Finland

Periodontitis complex

1.9

23.0

352

1897

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.5

22.6

789

5386

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.7

22.3

451

2665

SJC50

NOMESCO Finland

Removal of orthodontisk device with at least 7 brackets

1.9

22.2

349

1896

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

4.6

21.5

163

SJC00

NOMESCO Finland

Bracket with fixed attachment

6.2

21.5

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.8

21.3

240

K07.60

ICD-10 Finland

Snapping jaw

1.9

21.1

325

1754

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.1

20.8

EEC05

NOMESCO Finland

Le Fort I osteotomy

5.9

20.6

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.4

20.3

1241

9452

K07.30

ICD-10 Finland

Spacing, abnormal of tooth or teeth

1.8

20.2

357

2020

VALMI

NOMESCO Finland

1.3

19.9

1711

13769

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

19.8

4668

43406

ECB00

NOMESCO Finland

Suture of gingiva

2.4

19.7

172

729

EBB10

NOMESCO Finland

Insertion of dental implant

3.8

19.5

219

A11CC03

ATC

alfacalcidol; systemic

3.5

19.5

270

EB1MA

NOMESCO Finland

Cephalometry with X-ray

1.8

19.3

321

1781

K01.16

ICD-10 Finland

Retained molar with obstruction in the upper jaw

2.4

19.2

168

713

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.3

19.0

110

J01FF01

ATC

clindamycin; systemic

1.4

18.8

991

7340

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

18.7

2240

18863

SJD40

NOMESCO Finland

Fixation of ready made palatinal or lingual arrow

1.8

18.7

341

1951

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

18.6

817

5845

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.7

18.4

225

SJX10

NOMESCO Finland

Short check-up visit for orthodontisk therapy

1.6

18.4

542

3546

K00.6

ICD-10 Finland

Disturbances in tooth eruption

3.9

18.4

191

137

Kela drug reimbursment

Uraemia requiring dialysis

5.1

17.5

108

EB1WA

NOMESCO Finland

5.2

17.2

102

R4110

NOMESCO Finland

Physiotherapy

1.4

17.2

897

6620

SJB00

NOMESCO Finland

Fitting of loose orthodontic device with user information

1.7

17.0

359

2147

A12AA04

ATC

calcium carbonate; oral

4.1

16.8

163

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

3.8

16.7

183

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

16.7

1125

8672

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.4

16.5

828

6062

SJD30

NOMESCO Finland

Demanding attachment of arrow to fixed orthodontisk device

2.0

16.2

217

1115

N02BE01

ATC

paracetamol; systemic, rectal

1.3

16.1

3836

34967

J01DB01

ATC

cefalexin; oral

1.3

16.0

4181

38551

K07.24

ICD-10 Finland

Open bite

2.4

16.0

133

552

K01.19

ICD-10 Finland

Retained tooth with obstruction barrier UNS

7.4

15.8

SJC02

NOMESCO Finland

Positioning and fixed attachment of brackets

2.0

15.7

211

1082

K01.10

ICD-10 Finland

Retained front tooth with obstruction in the upper jaw

12.1

15.7

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.6

15.7

WX002

NOMESCO Finland

Sedation and analgesia

1.5

15.6

570

3911

ZXA10

NOMESCO Finland

Bilateral

1.5

15.6

623

4361

K07.23

ICD-10 Finland

Deep bite

1.8

15.2

269

1527

SJC03

NOMESCO Finland

Positioning and fixed attachment of brackets, extensive

1.8

15.1

251

1393

ZXA00

NOMESCO Finland

Right side

1.4

15.1

688

4944

K03.66

ICD-10 Finland

Tooth plaque

1.6

15.0

378

2374

Z49.2

ICD-10 Finland

Other dialysis

5.4

14.6

SPC20

NOMESCO Finland

Attachment of crone of tooth to implant

4.4

14.6

118

Z54.0

ICD-10 Finland

Convalescence following surgery

2.7

14.3

359

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

14.2

267

1542

L04AD01

ATC

ciclosporin; systemic

2.6

13.7

383

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.0

13.7

179

914

ZXA05

NOMESCO Finland

Left side

1.4

13.4

618

4442

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.7

13.4

351

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

13.4

184

956

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.5

13.3

549

3867

A02BC05

ATC

esomeprazole; systemic

1.3

13.3

1213

9742

SJA04

NOMESCO Finland

Very demanding plan for orthodontic care

5.7

13.2

B05DA

ATC

Isotonic solutions

4.8

13.1

K01.14

ICD-10 Finland

Retained premolar with obstruction in the upper jaw

10.9

12.9

P01AB01

ATC

metronidazole; oral, rectal

1.3

12.9

1496

12386

SJA03

NOMESCO Finland

Demanding plan for orthodontic care

6.1

12.7

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

12.7

1495

12394

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

12.6

1617

13552

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

12.6

497

3470

K01

ICD-10 Finland

Embedded and impacted teeth

2.5

12.5

100

409

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

12.4

738

5551

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

12.4

680

5044

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

12.3

190

1031

K07.25

ICD-10 Finland

Anomalies of dental arch relationship

1.9

12.3

184

988

SJC40

NOMESCO Finland

Removal of orthodontisk device with at most 6 brackets

1.6

12.3

296

1838

K06.18

ICD-10 Finland

Another gingival hyperplasia

5.2

12.3

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.1

12.3

134

636

N02AX02

ATC

tramadol; systemic, rectal

1.3

12.2

1177

9507

K03.30

ICD-10 Finland

Internal granuloma of pulp

5.9

12.1

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.8

12.0

203

1137

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.1

12.0

K07.10

ICD-10 Finland

Asymmetry of jaw

3.9

11.9

119

K09.09

ICD-10 Finland

Odontogenic developmental cyst UNS

13.3

11.9

SJX21

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment

1.6

11.8

280

1730

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.6

11.7

141

Z94.4

ICD-10 Finland

Liver transplant status

5.8

11.7

EFB40

NOMESCO Finland

Removal of internal or external fixation device from facial bones

5.4

11.4

K05.31

ICD-10 Finland

Periodontitis pronounced

1.8

11.3

198

1125

EBA00

SPAT

2.2

11.2

112

512

K07.38

ICD-10 Finland

Other anomaly in the position of the teeth

1.9

11.2

163

868

TJW99

NOMESCO Finland

Other minor procedure in gastrointestinal endoscopy

9.5

11.2

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

10.9

436

3049

B05DB

ATC

Hypertonic solutions

4.8

10.9

WX704

NOMESCO Finland

Intubation

1.6

10.7

256

1588

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

10.5

10.7

L03

ICPC

Low back symptom/complaint

1.3

10.5

1070

8683

B03XA01

ATC

erythropoietin; parenteral

4.4

10.4

EBA10

SPAT

2.9

10.4

210

TK800

NOMESCO Finland

Hemodialysis

2.8

10.4

239

K08.3

ICD-10 Finland

Retained dental root

1.8

10.4

177

996

EBB15

NOMESCO Finland

Insertion of dental implant abutment

3.7

10.3

120

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.3

10.2

K07.1

ICD-10 Finland

Anomalies of jaw-cranial base relationship

5.2

10.2

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

10.1

283

1828

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

10.1

1394

11729

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.1

9.9

107

509

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

9.8

102

478

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

2.0

9.7

120

602

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

9.7

1743

15062

5AB14

NOMESCO Finland

6.9

9.7

K12.2

ICD-10 Finland

Cellulitis and abscess of mouth

2.8

9.7

204

K08.80

ICD-10 Finland

Toothache NOS

1.5

9.5

379

2650

N18.0

ICD-10 Finland

End-stage renal disease

3.8

9.5

H02AB04

ATC

methylprednisolone; systemic

1.4

9.5

383

2683

KAY20

NOMESCO Finland

1.5

9.5

274

1787

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

9.4

2883

26178

EB1BD

NOMESCO Finland

Extensive cone beam CT of teeth and jaws (two quarters)

7.5

9.3

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

9.3

640

4917

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.8

9.3

198

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

8.9

242

1555

K05.39

ICD-10 Finland

Periodontitis UNS

2.9

8.9

180

R50.9

ICD-10 Finland

Fever, unspecified

1.3

8.9

630

4859

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

7.4

8.9

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

8.8

490

3638

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

3.3

8.8

132

K06.19

ICD-10 Finland

Gingival hyperplasia UNS

4.3

8.8

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.5

8.8

329

2270

B03XA02

ATC

darbepoetin alfa; parenteral

3.0

8.8

160

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

8.8

468

3452

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

8.7

1739

15145

TK820

NOMESCO Finland

Peritoneal dialysis

4.9

8.7

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.2

8.7

1050

8676

EB1KA

NOMESCO Finland

Partial (restricted area) panoramic tomography of teeth or jaw

3.2

8.7

139

G50.1

ICD-10 Finland

Atypical facial pain

2.6

8.4

239

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

8.4

1169

9817

Z94.1

ICD-10 Finland

Heart transplant status

5.9

8.4

SJX11

NOMESCO Finland

Therapeutic intervention or check-up related to orthodontic treatment, restricted

1.4

8.4

342

2405

EB1AD

NOMESCO Finland

Cone beam CT of teeth and jaws (one quarter)

4.2

8.3

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

8.3

519

3929

H02AB09

ATC

hydrocortisone; systemic

1.9

8.3

115

607

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

8.3

182

1110

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.3

8.2

830

6714

K03.00

ICD-10 Finland

Approximal wear

1.6

8.2

203

1277

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

5.5

8.2

K05.18

ICD-10 Finland

Chronic gingivitis

1.5

8.2

244

1605

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

4.7

8.2

A02BC03

ATC

lansoprazole; oral

1.3

8.1

665

5234

SAC03

NOMESCO Finland

Separate planning of oral and dental treatment, very demanding

2.6

8.1

223

SJX20

NOMESCO Finland

Check-up visit for orthodontisk therapy

1.5

8.0

278

1892

K07.14

ICD-10 Finland

Retrognaty, maxillary

2.7

8.0

186

N03AX12

ATC

gabapentin; oral

1.4

8.0

401

2928

ECB15

NOMESCO Finland

Plastic repair of oronasal or oroantral fistula

4.4

8.0

EBB11

NOMESCO Finland

Insertion of additional dental implant in one session

4.0

8.0

C03CA01

ATC

furosemide; systemic

1.4

7.9

342

2430

UJF32

NOMESCO Finland

Coloscopy

1.3

7.8

591

4601

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

7.8

455

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

1.7

7.8

159

952

SMAK

NOMESCO Finland

2.8

7.8

162

K00.29

ICD-10 Finland

Other or indefinite deviation in the shape or size of the teeth

8.4

7.8

J01CA04

ATC

amoxicillin; systemic

1.2

7.7

4696

44910

L17

ICPC

Foot/toe symptom/complaint

1.2

7.7

1003

8354

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

7.7

324

SAC02

NOMESCO Finland

Separate planning of oral and dental treatment, demanding

1.6

7.6

171

1050

J02AC01

ATC

fluconazole; systemic

1.2

7.6

1635

14296

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.8

7.6

123

684

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

2.7

7.6

182

D54

ICPC

Digestive, Repair/fix-suture/cast/prosth device

24.9

7.5

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

7.5

593

4643

H29

ICPC

Ear symptom/complaint other

1.4

7.5

340

2442

ZX120

NOMESCO Finland

Intravenous

1.5

7.5

277

1912

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

2.0

7.5

480

K05.3

ICD-10 Finland

Chronic periodontitis

1.9

7.5

104

549

R11

ICD-10 Finland

Nausea and vomiting

1.4

7.4

361

2623

C02CA01

ATC

prazosin; oral

4.4

7.4

602

Kela drug reimbursment

Children's severe malnutrition

2.4

7.3

230

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.5

7.3

N18.8

ICD-10 Finland

Other chronic renal failure

2.4

7.3

250

H02AB06

ATC

prednisolone; systemic

1.2

7.3

1586

13885

D01

ICPC

Abdominal pain/cramps general

1.3

7.2

664

5309

K09.00

ICD-10 Finland

Cyst dentigerous

15.6

7.2

K09.08

ICD-10 Finland

Another edontogenic developmental cyst

15.6

7.2

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

7.2

362

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

7.2

311

2215

R03AC02

ATC

salbutamol; inhalant

1.2

7.2

2397

21728

KAY40

NOMESCO Finland

1.4

7.1

313

2231

WX720

NOMESCO Finland

Own respiration

1.8

7.1

115

640

101

Kela drug reimbursment

Anterior pituitary hypofunction

2.6

7.1

179

R51.80

ICD-10 Finland

Headache

1.2

7.1

779

6365

K00.40

ICD-10 Finland

Postnatal enamel hypoplasia

2.0

7.0

420

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

7.0

552

4323

K03.80

ICD-10 Finland

Irradiated enamel

1.5

7.0

199

1295

XF602

NOMESCO Finland

Bloodpressure monitoring

2.7

7.0

165

K07.04

ICD-10 Finland

Macrognathism (mandibular)(maxillary)

5.6

7.0

EDC30

NOMESCO Finland

Genioplasty

9.9

7.0

K10.21

ICD-10 Finland

Osteoradionecrosis of jaw (acute)(chronic)(suppurative)

9.9

7.0

K07.4

ICD-10 Finland

Malocclusion, unspecified

1.9

6.9

494

SJA01

NOMESCO Finland

Estimation of need for orthodontic care

3.3

6.9

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.9

6.9

139

C08CA02

ATC

felodipine; oral

1.8

6.9

109

603

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.3

6.9

249

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

10.9

6.8

WX110

SPAT

1.5

6.7

214

1433

EBA12

SPAT

5.0

6.7

KAY60

NOMESCO Finland

1.6

6.7

153

944

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.5

6.7

J01MA02

ATC

ciprofloxacin; systemic

1.2

6.7

1079

9173

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

6.6

204

1356

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.4

6.6

ECB20

NOMESCO Finland

Oral alveoplasty

3.4

6.6

S18

ICPC

Laceration/cut

1.2

6.6

1391

12125

EWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of teeth, jaws, mouth and pharynx

7.7

6.6

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.3

6.5

256

M48.0

ICD-10 Finland

Spinal stenosis

1.7

6.4

132

792

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

6.4

732

5996

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

5.3

6.4

R74

ICPC

Upper respiratory infection acute

1.2

6.4

1947

17476

K03.5

ICD-10 Finland

Ankylosis of teeth

7.3

6.4

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.9

6.4

459

Z29.8

ICD-10 Finland

Other specified prophylactic measures

1.7

6.4

133

805

L01

ICPC

Neck symptom/complaint

1.3

6.3

577

4605

EB1HA

SPAT

2.5

6.3

186

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

6.3

1179

10161

ECB40

NOMESCO Finland

Surgical treatment of fracture of alveolus

3.3

6.3

196

Kela drug reimbursment

Paricalcitol and cinacalcet

4.5

6.2

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.3

6.2

379

2860

186

Kela drug reimbursment

Growth retardation associated with renal failure (growth hormone)

3.2

6.2

S29

ICPC

Skin symptom/complaint other

1.3

6.2

640

5191

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

6.2

105

599

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

1.8

6.1

103

586

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

3.5

6.1

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

6.1

163

1052

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

6.1

740

6109

WX1PA

NOMESCO Finland

Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)

4.4

6.1

A02BC02

ATC

pantoprazole; systemic

1.2

6.1

2072

18736

A28

ICPC

Limited function/disability NOS

1.5

6.1

215

1475

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.3

6.1

214

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.9

6.1

412

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3026250) Tacrolimus [Mass/volume] in Blood

261

3.72

30.80

38.6

39.3

ug/l

7.1

7.2

0.13

240

(3010375) cycloSPORINE [Mass/volume] in Blood

251

3.58

27.15

33.2

27.4

ug/l

113.8

130.5

0.95

212

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

118

4.73

24.58

6.8

6.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

224

1066

2.12

23.84

8.5

6.2

iu/ml

605.7

603.5

0.00

119

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

182

828

2.21

21.73

6.4

4.3

u/ml

1014.4

1257.8

—

(42870588) Differential panel, method unspecified - Blood

2099

17169

1.30

21.03

7.8

6.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

325

1873

1.75

19.50

2.1

1.9

—

(3047181) Lactate [Moles/volume] in Blood

203

1005

2.03

19.49

4.5

5.7

mmol/l

1.3

1.2

0.39

178

886

(3018010) Neutrophils/100 leukocytes in Blood

3025

26173

1.26

18.60

7.1

5.7

55.1

55.4

0.83

2869

24735

(3002030) Lymphocytes/100 leukocytes in Blood

3057

26539

1.25

18.05

7.4

5.9

31.0

30.7

0.64

2895

25009

(3006504) Eosinophils/100 leukocytes in Blood

2888

24939

1.25

17.77

7.5

6.0

2.7

2.8

1.76

2734

23369

(3019069) Monocytes/100 leukocytes in Blood

2901

25122

1.25

17.22

7.8

6.2

8.0

0.33

2758

23703

(3022096) Basophils/100 leukocytes in Blood

2782

24000

1.25

17.02

7.6

6.1

0.6

0.28

2627

22510

(3013707) Erythrocyte sedimentation rate by Westergren method

4018

36234

1.24

15.86

4.2

3.5

mm/h

8.5

8.4

0.31

3802

33750

(3019198) Lymphocytes [#/volume] in Blood

3153

27717

1.23

15.81

7.3

5.9

e9/l

2.0

0.16

2861

24890

(3024561) Albumin [Mass/volume] in Serum or Plasma

1969

16431

1.26

15.80

6.4

4.7

g/l

37.2

37.3

0.34

1863

15280

(3006315) Basophils [#/volume] in Blood

3016

26402

1.23

15.68

7.5

6.0

e9/l

0.0

0.01

2683

23164

(3001604) Monocytes [#/volume] in Blood

3007

26326

1.23

15.58

7.5

6.0

e9/l

0.5

0.62

2675

23140

(3013115) Eosinophils [#/volume] in Blood

3111

27339

1.23

15.54

7.9

6.3

e9/l

0.2

1.66

2807

24399

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

500

3409

1.49

14.96

2.3

2.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2217

18865

1.24

14.74

9.4

5.9

mmol/l

1.2

0.20

1922

16102

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

261

1532

1.71

14.73

9.8

10.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

3382

30114

1.22

14.44

9.8

8.1

e9/l

3.9

4.0

1.51

3014

26410

(3019150) Specific gravity of Urine by Refractometry

1500

12288

1.27

13.74

3.8

3.1

kg/l

1.0

2.05

210

1815

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

296

1831

1.63

13.69

3.6

3.0

ng/l

124.0

125.4

0.03

264

1575

(3037467) Urinalysis macro (dipstick) panel - Urine

4081

37241

1.21

12.83

4.5

3.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

543

3879

1.42

12.69

2.0

1.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.87

12.42

5.0

4.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1941

16517

1.23

12.42

4.1

3.0

u/l

30.4

29.3

0.52

1869

15725

(3023368) Bacteria identified in Blood by Culture

1153

9268

1.28

12.17

4.8

3.7

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.79

12.17

5.1

4.9

—

(3042733) HLA Ab [Presence] in Serum

183

2.94

12.08

5.1

4.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2417

21128

1.21

11.58

6.3

5.0

umol/l

10.0

10.3

0.88

2254

19645

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

546

3968

1.39

11.55

2.0

1.6

—

(3039000) Anion gap in Blood

122

612

1.99

11.46

5.4

7.8

mmol/l

11.1

11.6

0.63

106

551

(3015377) Calcium [Moles/volume] in Serum or Plasma

1545

12925

1.24

11.46

3.2

2.7

mmol/l

2.3

2.4

0.51

1399

11631

(3018572) Chloride [Moles/volume] in Blood

122

613

1.99

11.41

5.4

7.8

mmol/l

105.0

105.7

0.81

106

552

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1613

13564

1.23

11.39

2.7

2.5

u/l

57.4

55.2

0.46

1500

12523

(3018418) pH of Serum or Plasma

1299

10671

1.25

11.35

5.2

3.5

7.4

0.46

218

2048

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

683

5163

1.34

11.27

3.2

2.4

23.3

24.0

0.65

584

4505

(3022948) Iron [Moles/volume] in Serum or Plasma

823

6399

1.31

11.16

3.0

2.3

umol/l

14.4

14.7

0.49

775

5953

(3004789) Transferrin [Mass/volume] in Serum or Plasma

746

5725

1.33

11.10

3.0

2.3

g/l

2.5

0.52

706

5305

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

352

2382

1.49

10.96

7.8

4.4

ng/l

81.8

71.4

1.41

338

2189

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3727

33975

1.19

10.95

7.6

6.1

u/l

77.0

74.9

1.37

3538

31898

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

3.67

10.91

8.0

7.5

mg/l

2.4

2.6

0.18

(3003396) Base excess in Arterial blood by calculation

441

3120

1.43

10.89

9.0

8.0

mmol/l

0.8

0.6

0.36

327

2310

(3015736) pH of Urine

2411

21160

1.20

10.87

3.4

2.9

—

5.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

781

6064

1.31

10.68

2.0

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

180

1047

1.72

10.60

4.5

5.8

0.9

0.11

165

976

(3007853) Bacteria identified in Skin by Aerobe culture

758

5880

1.31

10.43

1.8

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

141

3.03

10.24

3.5

2.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1967

17028

1.20

10.14

9.2

5.5

mmol/l

1.2

0.09

1817

15586

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

390

2743

1.43

9.96

1.9

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

663

5089

1.32

9.83

12.4

6.4

mmol/l

1.1

1.47

634

4789

(40758558) Short blood count panel - Blood

1470

12425

1.22

9.64

7.6

6.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

731

5718

1.30

9.43

3.5

2.7

29.6

29.5

0.28

706

5522

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.55

9.20

5.1

4.5

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3908

36042

1.17

9.15

4.5

3.9

e6/l

2082.6

1453.9

0.14

431

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

782

6194

1.28

9.14

3.3

2.8

ng/l

609.5

480.4

0.30

413

3108

(3005719) IgG [Mass/volume] in Serum or Plasma

534

4015

1.34

9.12

3.0

2.6

g/l

10.0

10.5

2.43

505

3706

(3027945) Reticulocytes/100 erythrocytes in Blood

493

3663

1.36

9.11

4.4

3.5

1.6

0.66

449

3299

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

428

3115

1.38

9.00

9.0

8.0

kpa

5.0

0.09

404

2985

(3027801) Oxygen [Partial pressure] in Arterial blood

427

3114

1.38

8.87

8.9

8.0

kpa

13.9

14.0

0.16

404

2985

(3000034) Microalbumin [Mass/volume] in Urine

265

2.33

8.83

3.1

mg/l

52.2

42.8

0.12

202

(3016502) Oxygen saturation in Arterial blood

382

2744

1.40

8.69

9.7

8.5

96.4

96.5

0.09

357

2647

(3020779) Urea [Moles/volume] in Serum or Plasma

425

3114

1.37

8.58

15.5

8.4

mmol/l

7.6

6.7

2.41

417

2993

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1729

14988

1.19

8.50

1.7

1.6

pmol/l

99.1

97.7

0.61

922

8447

(3035350) Ketones [Presence] in Urine by Test strip

2982

27022

1.16

8.49

3.7

3.1

estimate

0.0

1.47

568

5536

(3008152) Bicarbonate [Moles/volume] in Arterial blood

247

1643

1.51

8.44

7.1

7.0

mmol/l

24.3

23.9

0.70

222

1537

(3012095) Magnesium [Moles/volume] in Serum or Plasma

724

5746

1.28

8.32

7.4

4.3

mmol/l

0.8

5.65

684

5411

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

172

1064

1.62

8.11

4.1

5.7

1.8

1.7

0.13

157

990

(3002173) Hemoglobin [Mass/volume] in Arterial blood

356

2561

1.40

8.05

9.5

8.7

g/l

120.3

123.7

2.42

333

2478

(40768446) Kidney Pathology biopsy report

221

2.38

8.01

2.2

1.7

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.31

8.01

7.0

6.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

238

1591

1.50

7.96

15.0

7.8

mg/l

1.3

1.2

2.74

231

1517

(44790049)

528

1.85

7.59

2.3

1.6

—

(44790047)

528

1.85

7.59

2.3

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

346

2503

1.39

7.58

3.3

3.1

e9/l

65.9

71.0

1.97

251

1782

(44790048)

529

1.85

7.55

2.3

1.6

—

(44806118)

529

1.85

7.55

2.3

1.6

—

(3042936) Bacteria identified in Isolate by Culture

711

5698

1.26

7.53

2.2

1.9

—

(3002385) Erythrocyte distribution width [Ratio]

5200

49368

1.18

7.51

15.1

11.6

13.2

13.3

0.76

5101

48354

(3026008) Bacteria identified in Urine by Culture

1675

14613

1.18

7.49

2.6

2.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2248

20073

1.16

7.49

2.8

2.3

nmol/l

71.0

70.0

1.06

2122

18810

(3021447) Carbon dioxide [Partial pressure] in Venous blood

498

3819

1.31

7.44

9.4

4.8

kpa

5.9

0.15

480

3690

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

151

925

1.63

7.44

2.3

1.7

—

(3048689) Calprotectin [Mass/mass] in Stool

1121

9452

1.21

7.35

2.7

2.8

ug/g

101.4

110.5

0.50

894

7391

(3000991) Gas panel - Venous blood

461

3505

1.32

7.33

12.7

8.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2924

26656

1.15

7.26

5.7

4.2

mmol/l

6.2

0.34

2576

23508

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

358

2626

1.37

7.22

10.7

5.1

mmol/l

24.1

24.0

0.46

335

2451

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

100

553

1.80

7.15

1.6

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

306

2194

1.40

7.09

1.1

u/ml

4.3

0.01

318

(3002032) Base excess in Venous blood by calculation

492

3793

1.31

7.08

9.5

4.8

mmol/l

1.7

1.6

0.25

384

3044

(3009261) Glucose [Presence] in Urine by Test strip

2977

27213

1.15

7.03

3.7

3.1

estimate

0.0

0.25

576

5625

(3044889) 12 lead EKG panel

3046

27903

1.15

6.95

2.9

2.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

107

613

1.74

6.81

1.9

1.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1423

12337

1.18

6.78

2.4

2.2

mg/l

2.5

2.6

2.20

1262

10589

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3278

30211

1.14

6.77

3.2

2.9

ug/l

72.3

67.4

0.93

3144

28568

(3021601) Nitrite [Presence] in Urine by Test strip

2955

27046

1.14

6.76

5.0

4.2

estimate

0.0

1.60

590

5777

(3011397) Hemoglobin [Presence] in Urine by Test strip

1412

12238

1.18

6.75

3.6

3.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

272

1930

1.41

6.71

4.5

3.4

g/l

3.4

3.5

0.63

257

1827

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4647

43870

1.15

6.70

4.0

3.9

pmol/l

14.4

0.02

4297

40153

(3028026) IgM [Mass/volume] in Serum or Plasma

405

3069

1.33

6.61

2.0

1.7

g/l

1.2

1.3

0.72

386

2862

(3019060) Gas panel - Arterial blood

235

1630

1.44

6.58

5.4

5.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

276

1972

1.40

6.55

3.8

2.5

e6/l

0.2

1.40

264

1898

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1940

17277

1.16

6.50

1.4

u/ml

1.4

1.7

0.62

481

4611

(3032080) INR in Blood by Coagulation assay

1495

13055

1.17

6.49

6.7

5.1

inr

1.1

0.37

537

4698

(3041806) Other cells [#/volume] in Blood by Manual count

162

1047

1.54

6.42

1.5

1.4

—

(3026782) Osmolality of Urine

1039

8807

1.20

6.39

3.2

2.5

mosm/kgh2o

516.8

565.6

0.60

898

7511

(3023103) Potassium [Moles/volume] in Serum or Plasma

5265

50231

1.16

6.33

12.6

9.2

mmol/l

3.9

2.66

5087

48406

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

260

1853

1.40

6.28

4.8

3.1

159.7

163.2

0.30

253

1754

(3021960) Folate [Moles/volume] in Serum or Plasma

982

8296

1.20

6.25

1.5

1.4

nmol/l

20.1

19.8

0.25

869

7436

(3019550) Sodium [Moles/volume] in Serum or Plasma

5251

50126

1.16

6.10

12.5

9.2

mmol/l

139.4

139.5

3.00

5088

48454

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

464

1.80

6.09

3.5

2.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

146

939

1.55

5.95

2.2

1.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

271

1966

1.38

5.91

4.6

3.4

94.8

94.3

0.12

258

1833

(3000850) Epithelial cells [#/volume] in Urine

1102

9455

1.18

5.88

3.1

2.4

e6/l

7.3

8.4

1.52

964

8222

(3029634) Reagin Ab [Titer] in Serum by VDRL

195

1336

1.46

5.87

2.1

1.7

titre

4.3

4.5

—

(3003338) MCHC [Mass/volume]

5410

51801

1.16

5.87

15.1

11.6

g/l

334.0

333.8

0.53

5373

51332

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

611

4953

1.24

5.86

4.8

3.0

umol/l

5.9

6.4

0.57

519

4157

(3007164) IgA [Mass/volume] in Serum or Plasma

1651

14631

1.15

5.82

1.5

1.4

g/l

2.0

1.06

1047

9095

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1242

10776

1.17

5.78

2.3

2.0

mg/l

1.2

1.0

0.83

874

7553

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

265

1924

1.38

5.76

1.3

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5736

55199

1.18

5.74

12.4

9.5

mg/l

19.7

20.3

0.68

4443

41288

(3035637) Corticotropin [Mass/volume] in Plasma

120

744

1.61

5.73

1.7

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5235

50029

1.15

5.72

4.7

4.4

mu/l

1.9

0.06

5027

47262

(3026493) Urate [Moles/volume] in Serum or Plasma

1056

9051

1.18

5.69

3.2

2.4

umol/l

2370.8

2973.4

0.29

962

8141

(3037522) Nuclear Ab [Titer] in Serum

879

7429

1.20

5.56

1.4

titre

479.2

542.3

0.49

154

1364

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

274

2019

1.36

5.45

1.6

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

262

1917

1.37

5.45

1.6

1.3

u/ml

231.4

230.8

0.01

161

1140

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

699

5795

1.22

5.41

2.5

2.4

mmol/l

2.4

1.62

623

5004

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

280

2074

1.35

5.39

1.5

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

556

4509

1.24

5.33

1.3

u/ml

230.1

251.3

0.17

507

4159

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

500

1.71

5.29

3.3

2.5

10.4

11.1

0.23

320

(3016244) Insulin [Units/volume] in Serum or Plasma

122

776

1.57

5.27

3.3

3.2

mu/l

25.7

27.6

0.11

115

721

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

490

3929

1.25

5.20

4.6

4.2

u/l

224.9

234.3

0.93

466

3748

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4759

45287

1.13

5.19

3.1

3.0

mmol/l

5.5

0.10

4503

42269

(40768804) Tissue Pathology biopsy report

1986

17961

1.13

5.07

1.9

1.8

—

(36660697) Celiac disease serology panel - Serum

747

6279

1.20

5.01

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

223

1614

1.38

5.00

2.1

1.4

u/ml

102.6

106.0

0.25

299

(3011412) CD3 cells [#/volume] in Blood

600

1.63

4.98

3.4

2.8

e9/l

1.4

1.2

1.45

353

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.82

4.97

2.7

2.1

—

(3025315) Body weight

4.74

4.94

2.4

2.7

—

(3002582) Erythrocytes [#/volume] in Urine

1542

13742

1.14

4.91

3.8

2.9

e6/l

121.4

77.3

0.25

1216

10205

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2308

21102

1.12

4.89

3.6

3.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

232

1704

1.36

4.76

2.0

1.4

u/ml

15.9

19.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

446

3578

1.25

4.74

3.4

2.9

g/l

0.2

0.03

421

3354

(3024354) Oxygen [Partial pressure] in Venous blood

414

3295

1.26

4.71

9.4

4.5

kpa

5.0

4.8

0.72

400

3177

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.04

4.69

2.1

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

163

1131

1.44

4.67

2.8

2.4

ug/l

622.4

327.1

0.57

151

988

(21494815) CD4 cells/100 lymphocytes in Specimen

534

1.64

4.66

3.5

2.6

35.7

45.2

—

(3019977) pH of Arterial blood

144

2.27

4.65

5.0

2.8

7.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

618

5157

1.20

4.50

2.3

2.0

nmol/l

376.9

387.0

0.59

583

4755

(3029937) Albumin [Presence] in Urine by Test strip

1635

14712

1.13

4.44

3.9

3.3

estimate

0.0

0.58

573

5633

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

144

988

1.45

4.41

1.3

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

522

4297

1.22

4.37

1.6

1.5

iu/l

15.5

15.0

0.13

438

3554

(3017181) Myelocytes/100 leukocytes in Blood

460

3739

1.23

4.36

4.3

4.4

0.9

0.7

0.51

111

889

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

498

1.64

4.35

3.4

2.9

e6/l

591.9

539.2

0.51

403

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

816

6999

1.18

4.34

3.1

2.6

e6/l

4.3

0.03

462

3558

(3036489) Thrombin time

280

2145

1.30

4.34

4.1

2.8

21.4

21.1

0.76

246

1824

(3017704) Immunofixation for Urine

2.59

4.29

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

694

5879

1.19

4.28

3.3

3.1

ng/l

1091.6

761.4

1.28

571

4610

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

113

743

1.51

4.28

7.5

5.7

u/ml

0.3

2.25

401

(3000494) Fungus identified in Specimen by Culture

616

5172

1.20

4.20

1.6

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1273

11308

1.14

4.20

2.2

2.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

101

2.46

4.19

5.9

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

101

2.46

4.19

5.9

2.5

—

(3020393) Adenovirus Ag [Presence] in Stool

132

2.26

4.18

2.2

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

296

1.81

4.14

3.8

2.9

e6/l

232.6

227.7

0.03

181

(3000570) Elastase.pancreatic [Mass/mass] in Stool

145

1010

1.43

4.12

1.2

1.3

ug/g

294.9

321.5

0.69

484

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

492

1.62

4.07

3.4

2.9

e9/l

0.2

0.40

407

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1135

10030

1.14

4.04

2.3

2.1

u/l

185.2

219.5

0.84

1090

9533

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

194

2.00

4.00

4.5

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

194

2.00

4.00

4.5

2.0

—

(3037121) Protein [Mass/volume] in Urine

219

1641

1.33

4.00

3.7

4.0

g/l

0.4

0.01

124

835

(3025159) Blasts/100 leukocytes in Blood

424

3451

1.23

3.99

4.5

0.1

0.2

0.41

724

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

135

935

1.44

3.97

1.5

mmol/l

9.9

11.2

—

104

(3018095) Leukocytes [#/volume] in Urine

1915

17493

1.12

3.96

4.3

3.3

e6/l

65.0

67.4

0.07

1297

11164

(40761511) CBC panel - Blood by Automated count

6012

58388

1.16

3.88

10.9

8.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

929

8123

1.15

3.85

1.3

u/ml

7.6

8.9

0.31

344

3290

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.23

3.83

10.5

7.0

mmol/l

5.2

6.3

0.90

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

547

1.56

3.82

2.3

1.6

—

(3011648) Oxygen content in Venous blood

326

1.74

3.82

14.6

5.1

11.1

11.4

0.22

326

(3037756) Immunofixation for Serum or Plasma

326

1.74

3.82

1.7

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

401

1.66

3.81

1.9

1.5

—

(3024932) HLA-DR beta [Type]

191

1.97

3.81

1.1

—

(3024471) HLA-A [Type]

191

1.97

3.81

1.1

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

449

1.62

3.74

1.9

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

270

1.80

3.73

2.3

2.8

42.1

43.6

0.22

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

872

7611

1.15

3.71

1.5

pmol/l

80488229.8

37731973.2

0.78

779

6586

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

116

793

1.46

3.68

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

230

1760

1.30

3.65

2.0

1.9

g/l

0.2

0.35

216

1676

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

225

1718

1.31

3.63

2.1

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

477

1.58

3.60

1.9

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1033

11403

0.88

3.60

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

1351

12164

1.12

3.56

4.0

3.4

mmol/l

8.2

8.6

1.41

1186

10759

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5487

53044

1.12

3.50

4.2

4.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

422

3483

1.21

3.50

4.1

0.5

0.06

671

(3004119) Hemoglobin [Mass/volume] in Venous blood

240

1862

1.29

3.45

8.1

3.8

g/l

127.7

132.9

3.40

228

1821

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1145

10232

1.13

3.42

1.7

1.6

mmol/l

1.4

1.3

0.62

1042

9035

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

121

847

1.42

3.42

1.6

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

433

3592

1.21

3.41

4.4

0.1

0.60

106

832

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

121

848

1.42

3.40

1.6

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

345

2799

1.23

3.39

2.5

2.3

ml/min/173m2

79.8

83.0

0.58

131

988

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

195

1476

1.32

3.38

12.8

10.6

mmol/l

24.0

24.1

0.12

186

1409

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.45

3.38

1.5

1.4

nmol/l

17.7

14.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

144

1041

1.38

3.38

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

233

1807

1.29

3.37

1.9

g/l

1.2

0.48

220

1724

(3000492) Spirometry study

611

5230

1.17

3.37

1.4

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

1210

10862

1.12

3.35

5.9

3.8

94.0

94.4

0.26

1175

10559

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4100

39098

1.10

3.33

4.1

3.7

mmol/mol

36.9

36.8

0.08

3924

37018

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

145

1052

1.37

3.33

1.2

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

511

1.54

3.31

1.8

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

272

2157

1.26

3.29

1.3

u/ml

1.2

1.0

0.09

170

(3022493) Free Hemoglobin [Mass/volume] in Plasma

209

1.85

3.28

5.7

5.5

mg/l

76.6

3584.9

1.34

163

(3022145) Colonoscopy Study observation

536

4553

1.18

3.25

1.5

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

189

1.89

3.23

1.9

1.8

—

(3051651) Icteric interference index of Serum or Plasma

299

1.69

3.19

6.8

3.6

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

126

901

1.39

3.18

8.5

3.2

mmol/l

23.2

23.9

1.53

114

811

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

399

1.59

3.16

2.0

1.7

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5775

56071

1.13

3.16

9.3

7.6

u/l

25.9

25.7

0.19

5620

54231

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1529

13950

1.11

3.15

2.3

2.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

977

8691

1.13

3.14

1.3

iu/ml

18.2

22.4

1.18

283

2392

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

168

1260

1.33

3.13

1.1

au/ml

3.8

13.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

518

4414

1.17

3.04

1.5

1.3

—

(3034426) Prothrombin time (PT)

215

1.80

3.03

1.4

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

125

901

1.38

3.02

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

237

1870

1.26

3.02

2.1

1.9

u/l

38.2

39.2

0.38

220

1745

(3019309) Folate [Moles/volume] in Red Blood Cells

633

5482

1.16

3.02

1.6

nmol/l

1158.4

1171.6

0.14

498

4240

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.56

2.97

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

598

1.46

2.96

1.4

g/l

0.4

0.08

428

(3027273) Bicarbonate [Moles/volume] in Venous blood

176

1341

1.31

2.96

4.8

3.8

mmol/l

24.8

25.0

0.28

168

1294

(3009445) Proteinase 3 Ab [Units/volume] in Serum

220

1726

1.27

2.95

1.5

1.6

u/ml

14.2

8.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

144

1067

1.34

2.94

1.3

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

599

1.46

2.94

1.4

1.3

g/l

2.9

2.8

0.25

431

(3021589) Normoblasts [#/volume] in Blood

2579

24193

1.09

2.91

9.7

8.0

e9/l

0.0

0.67

2101

19843

(3030467) Casts [#/volume] in Urine by Automated count

1374

12516

1.11

2.91

3.6

2.8

e6/l

0.3

0.12

1058

9139

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1532

14035

1.10

2.90

1.6

1.5

—

(4062490)

605

1.45

2.80

1.5

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

143

1068

1.33

2.79

3.6

e9/l

3.5

3.9

1.87

143

1068

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

101

714

1.41

2.77

2.8

2.7

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

599

1.44

2.76

1.4

1.3

g/l

6.2

6.5

0.52

434

(3028626) Oxygen [Partial pressure] in Capillary blood

208

1636

1.27

2.76

10.0

4.6

kpa

9.6

9.5

0.26

199

1554

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2285

21365

1.09

2.75

1.9

1.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

123

901

1.36

2.73

1.4

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1275

11608

1.11

2.72

1.8

1.7

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

145

1091

1.32

2.70

4.4

3.8

51.9

55.7

3.33

145

1091

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4813

46415

1.09

2.68

3.3

3.0

mmol/l

4.6

0.44

4613

44160

(3014576) Chloride [Moles/volume] in Serum or Plasma

455

3882

1.17

2.66

10.2

7.0

mmol/l

104.7

105.0

0.79

446

3800

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

637

1.42

2.65

2.4

1.8

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

2.48

2.64

1.1

1.2

—

152.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.16

2.60

1.5

1.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

542

1.45

2.57

3.9

2.8

1.3

0.04

432

(3007566) Smooth muscle Ab [Titer] in Serum

181

1416

1.27

2.54

1.5

1.4

titre

66.8

87.3

0.93

152

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

182

1425

1.27

2.53

1.9

2.1

g/l

1.3

0.38

164

1261

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

423

1.50

2.52

3.3

1.6

111.5

118.9

0.51

400

(36304419) Bacteria [Presence] in Urine

1380

12664

1.10

2.50

3.5

2.8

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

464

1.48

2.50

1.2

1.3

titre

77.3

276.8

4.03

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

244

1.67

2.50

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

456

1.48

2.50

1.2

—

(3045424) Erythrocytes [Presence] in Urine

112

823

1.35

2.47

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

663

1.39

2.47

5.5

3.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

354

2979

1.19

2.47

15.1

12.1

inr

1.2

1.1

0.61

523

(3024980) IgG subclass 4 [Mass/volume] in Serum

124

926

1.33

2.46

1.7

g/l

0.8

0.7

0.13

719

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

145

1108

1.30

2.45

1.9

1.6

titre

697.1

3103.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

150

1153

1.29

2.43

2.6

2.7

—

(3024928) Oxygen saturation in Venous blood

105

767

1.36

2.41

12.0

4.0

—

(1761868) Lipid panel - Serum or Plasma

1800

18934

0.92

2.41

2.1

2.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

261

2141

1.21

2.40

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

2.43

2.39

1.4

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

659

1.39

2.39

3.5

1.7

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

453

1.47

2.38

3.1

3.0

e6/l

992.1

866.3

0.49

163

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

489

4237

1.15

2.37

2.5

2.4

u/l

38.1

46.4

0.31

422

3630

(3009214) Lutropin [Units/volume] in Serum or Plasma

428

3673

1.16

2.36

1.7

1.5

u/l

7.9

7.8

0.05

348

2979

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

149

1150

1.29

2.35

2.0

mg/l

11.4

9.9

1.66

141

1087

(3014111) Lactate [Moles/volume] in Serum or Plasma

363

3082

1.18

2.30

11.4

7.1

mmol/l

1.3

0.48

340

2935

(3008757) Leukocyte morphology finding [Identifier] in Blood

425

1.47

2.28

3.9

3.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

122

921

1.32

2.27

2.0

ug/l

3.8

1.9

0.76

818

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

213

1.68

2.27

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

442

1.46

2.26

2.7

1.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

944

0.70

2.25

2.0

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

314

1.55

2.25

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

386

1.49

2.24

6.5

3.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4820

46614

1.08

2.24

3.4

3.2

mmol/l

2.8

0.71

4604

44008

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1341

12353

1.09

2.23

2.8

2.5

ng/l

33.8

59.5

0.56

618

5055

(3028717) Thiamine [Mass/volume] in Blood

2.66

2.23

1.3

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.85

2.23

1.4

1.6

—

(40768797) Stomach Pathology biopsy report

589

5197

1.13

2.20

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

513

4489

1.14

2.18

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

208

1687

1.23

2.17

1.9

2.1

—

(4024509)

389

1.48

2.17

1.6

1.4

—

(4034850)

162

1279

1.26

2.16

11.5

6.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

142

1.82

2.16

1.0

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

335

2843

1.18

2.15

8.8

4.0

kpa

5.1

0.39

322

2685

(3022689) Creatine [Moles/volume] in Urine

2.03

2.15

1.1

1.7

—

(3045142) Bone marrow Pathology biopsy report

302

1.54

2.15

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

532

0.61

2.14

1.2

—

(3007461) Platelets [#/volume] in Blood

6453

63317

1.16

2.14

17.5

14.0

e9/l

261.5

262.8

0.95

6326

61762

(3045462) Protein/Creatinine [Ratio] in Urine

202

1.67

2.13

5.5

6.7

g/mol

54.8

49.9

0.09

182

(3044941) Cell count panel - Synovial fluid

465

1.43

2.11

1.4

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2312

21812

1.07

2.11

2.5

—

(3010813) Leukocytes [#/volume] in Blood

6463

63430

1.16

2.09

17.5

14.0

e9/l

6.7

6.8

1.99

6329

61783

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2657

25197

1.07

2.09

4.4

3.9

—

(3035941) MCH [Entitic mass]

6459

63389

1.16

2.08

17.4

13.9

29.9

29.8

1.30

6396

62665

(3020682) Albumin/Creatinine [Ratio] in Urine

873

7905

1.11

2.08

4.9

4.4

mg/mmol

11.3

12.7

0.39

616

5541

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.17

2.07

1.1

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

325

2762

1.17

2.07

9.0

4.1

mmol/l

1.0

1.1

0.37

222

1934

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

136

1059

1.28

2.05

1.6

—

(3024731) MCV [Entitic volume]

6458

63387

1.16

2.03

17.4

13.9

89.1

89.0

0.84

6395

62663

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.11

2.03

1.2

1.1

mg/l

127.5

224.4

0.24

(3020630) Protein [Mass/volume] in Serum or Plasma

242

2010

1.20

2.01

2.9

2.2

g/l

66.6

67.4

1.18

233

1880

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

801

7235

1.11

2.01

3.1

2.5

e6/l

1.1

0.11

452

3798

(3026361) Erythrocytes [#/volume] in Blood

6459

63404

1.16

2.00

17.4

14.0

e12/l

4.6

1.54

6326

61772

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4756

46047

1.07

1.99

3.2

3.0

mmol/l

1.5

0.47

4554

43710

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

515

5711

0.88

1.98

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

100

753

1.32

1.95

2.4

1.7

g/l

3.1

0.06

611

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

350

1.47

1.95

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

270

1.54

1.94

1.1

1.2

g/l

0.3

1.34

217

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.30

1.94

2.6

2.9

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

519

5744

0.89

1.93

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

378

4271

0.87

1.93

5.8

4.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

519

5740

0.89

1.91

1.4

—

(3028433) Virus identified in Specimen by Culture

178

1.67

1.91

1.5

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

518

5729

0.89

1.91

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

592

6493

0.89

1.89

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.96

1.89

1.8

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.92

1.89

1.5

1.3

—

(3009343) pH of Capillary blood

329

2822

1.16

1.89

9.0

4.0

7.4

0.05

298

(40760892) CBC W Ordered Manual Differential panel - Blood

1436

13361

1.08

1.88

4.5

4.1

—

(4035726)

310

2648

1.17

1.88

1.7

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

672

1.33

1.87

1.7

e6/l

14922.8

12785.4

0.14

495

(3041096) Erythrocytes [Presence] in Urine by Automated

1715

16072

1.08

1.85

3.1

2.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

190

1557

1.21

1.84

1.9

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

135

1067

1.26

1.83

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

121

1.80

1.82

1.0

u/ml

0.1

0.9

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

150

1202

1.24

1.81

1.1

u/ml

4.5

2.4

0.67

583

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

178

1453

1.22

1.80

8.5

3.6

0.7

0.09

167

1413

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

151

1.71

1.80

1.2

1.1

—

(3012516) Albumin [Mass/volume] in Urine

838

7637

1.10

1.78

4.1

3.6

mg/l

981.3

326.3

1.98

589

5314

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

115

1.81

1.77

1.2

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

208

1728

1.20

1.76

2.0

1.9

—

(3007542) Rye IgE Ab [Units/volume] in Serum

2.15

1.73

1.2

1.0

u/ml

0.2

0.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

451

1.39

1.73

1.3

u/ml

0.5

0.6

0.05

137

(3018738) Hemoglobin F/Hemoglobin.total in Blood

116

1.79

1.73

3.6

0.3

3.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

435

3836

1.13

1.70

3.2

3.3

pmol/l

4.7

0.04

391

3480

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

640

1.32

1.70

1.1

g/l

1.5

1.4

0.86

582

(3000963) Hemoglobin [Mass/volume] in Blood

6458

63448

1.14

1.69

17.6

14.1

g/l

135.3

135.6

1.21

6397

62722

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

117

1.78

1.68

2.7

2.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

297

2555

1.16

1.67

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

371

1.42

1.66

1.2

1.1

—

(4268621)

730

1.29

1.65

2.5

2.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1.93

1.64

1.0

ng/l

1003.8

760.3

—

(3023419) Bacteria identified in Sputum by Culture

306

1.46

1.64

4.0

3.8

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.36

1.64

2.0

1.8

ng/l

104.7

102.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

133

1066

1.24

1.63

1.3

u/ml

3.9

4.0

0.04

394

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

111

1.79

1.63

2.4

1.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

104

1.81

1.62

1.7

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.96

1.59

1.6

nmol/l

2.8

450854.3

0.72

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.22

1.59

1.4

1.6

g/l

8.4

13.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

101

787

1.27

1.58

2.4

1.7

g/l

7.4

7.3

0.16

626

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

101

787

1.27

1.58

2.4

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

101

787

1.27

1.58

2.4

1.7

g/l

3.9

3.7

0.54

590

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

419

4632

0.89

1.58

1.2

1.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

2.12

1.57

1.1

u/ml

0.2

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

401

1.39

1.56

2.1

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.85

1.55

1.9

1.7

mg/l

1.6

3.0

0.60

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

1.85

1.55

1.9

1.7

mg/l

2.7

1.6

0.22

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.85

1.55

1.9

1.7

mg/l

0.9

1.5

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.85

1.55

1.9

1.7

mg/l

1.6

2.0

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.85

1.55

1.9

1.7

mg/l

2.7

1.0

0.32

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

1.85

1.55

1.9

1.7

mg/l

1.7

2.7

0.29

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.85

1.55

1.9

1.7

mg/l

0.5

1.1

1.27

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.85

1.55

1.9

1.7

mg/l

2.0

4.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

253

1.49

1.55

1.2

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1.89

1.55

1.0

ng/l

29.1

43.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

231

1963

1.17

1.55

3.4

3.9

ug/l

3.8

39.5

1.19

171

1413

(3023183) Ammonium ion [Moles/volume] in Plasma

746

1.28

1.55

4.5

2.9

umol/l

33.9

32.1

0.31

647

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4546

44106

1.06

1.53

3.0

2.8

mmol/l

1.2

0.14

4346

41901

(3020961) Endomysium IgA Ab [Titer] in Serum

458

4082

1.12

1.53

1.1

1.2

titre

647.3

186.0

0.82

124

(1002224) Polysomnography panel

243

2077

1.16

1.52

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

370

1.39

1.51

1.2

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1.87

1.50

1.0

ng/l

230.3

280.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.25

1.49

1.1

—

(3036180) Methadone [Presence] in Urine

2.57

1.49

2.0

2.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.83

1.49

1.3

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

572

6194

0.91

1.48

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

1639

15454

1.07

1.47

2.5

2.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

128

1036

1.23

1.47

1.3

u/ml

3.7

4.4

0.35

493

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

129

1045

1.23

1.47

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

177

1.57

1.45

2.0

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.88

1.45

3.7

2.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

101

799

1.26

1.43

3.7

u/ml

265.7

1824.0

0.66

681

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.79

1.42

1.9

1.7

mg/l

1.4

0.03

(3043238) Trisomy 21 risk [Likelihood] in Fetus

422

4628

0.90

1.41

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

171

1.57

1.40

1.4

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

179

1.55

1.40

2.3

2.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

558

1.30

1.37

1.8

1.6

—

(3025130) Human papilloma virus identified in Specimen

145

1200

1.20

1.35

1.9

1.7

—

(3010503) CD19 cells [#/volume] in Blood

278

1.43

1.35

2.8

2.9

e9/l

0.2

0.04

272

(3049242) von Willebrand panel - Platelet poor plasma

2.58

1.35

1.5

1.3

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

413

1.35

1.34

1.1

u/ml

38.2

27.3

0.10

274

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.91

1.34

3.4

2.9

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.98

1.34

1.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

111

1.70

1.34

7.3

5.1

mmol/l

23.9

24.5

0.29

105

(4010399)

318

2799

1.13

1.34

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

621

1.28

1.34

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

716

7633

0.92

1.34

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

371

1.36

1.33

4.9

3.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

304

1.40

1.33

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

483

1.31

1.32

3.8

2.8

ratio

8.3

1.5

0.47

(3034860) Kappa light chains.free [Mass/volume] in Serum

492

1.31

4.3

2.9

mg/l

52.0

63.4

0.25

398

(3023420) DNA double strand Ab [Units/volume] in Serum

614

1.28

1.31

2.4

1.7

iu/ml

29.0

32.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

170

1432

1.18

1.31

1.4

1.3

u/ml

44.4

31.5

0.28

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

280

1.42

1.31

1.1

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.11

1.30

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

493

1.31

1.30

4.3

2.9

mg/l

47.9

35.2

0.54

400

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.95

1.29

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

167

1.54

1.29

1.4

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

487

1.30

1.26

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

316

1.38

1.26

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

772

7130

1.08

1.26

1.5

—

(4306422)

123

1011

1.21

1.25

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

141

1174

1.19

1.25

1.3

u/ml

38.6

38.7

0.00

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

488

1.30

1.24

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

445

1.32

1.24

3.5

4.3

mg/l

9.6

8.5

0.53

368

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

159

0.50

1.23

2.5

2.7

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.70

1.23

1.1

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1315

12386

1.06

1.22

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

138

1.58

1.21

1.0

1.1

—

(3024263) Appearance of Synovial fluid

146

1.56

1.21

2.3

2.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

146

1.56

1.21

1.0

1.1

—

(3001729) Color of Synovial fluid

2.61

1.20

1.0

1.9

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

694

1.24

1.19

1.3

u/ml

30.4

38.3

0.17

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

155

1309

1.18

1.19

1.4

1.3

u/ml

35.8

15.1

0.64

182

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

431

1.31

1.19

1.1

miu/ml

1281.7

1493.8

0.78

431

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

155

1.53

1.18

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.29

1.17

1.3

—

(3000330) Specific gravity of Urine by Test strip

163

1873

0.86

1.16

3.5

2.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

127

1057

1.19

1.16

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

547

1.27

1.15

1.7

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2092

19999

1.05

1.14

2.4

2.3

—

(3010421) pH of Blood

1065

0.82

1.12

5.0

3.6

7.4

0.04

909

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

585

1.25

1.11

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

497

1.28

1.11

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

308

1.35

1.09

1.8

2.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3854

37403

1.05

1.09

3.3

2.8

u/l

36.8

32.2

1.97

3712

35766

(3012501) Base excess in Blood by calculation

929

0.81

1.08

5.5

3.6

mmol/l

1.9

0.09

510

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

500

1.27

1.07

1.9

1.5

—

(3022313) Gas panel - Capillary blood

241

2122

1.13

1.06

9.2

4.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

174

1499

1.15

1.06

2.3

2.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

301

1.35

1.06

2.1

2.6

mg/l

10.1

9.7

0.17

252

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

151

1287

1.17

1.06

1.4

1.3

u/ml

6.8

9.8

0.25

121

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

221

1936

1.13

1.06

1.7

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

148

1260

1.17

1.06

4.5

2.7

—

(40757373) Influenza virus identified in Isolate

1.80

1.05

1.8

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

392

4239

0.91

1.05

2.9

33.2

32.3

0.95

305

3191

(3013336) Amino acids [Identifier] in Serum or Plasma

1.85

1.04

1.4

3.6

—

(3045788) Cell count panel - Pleural fluid

136

1.53

1.04

1.3

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

725

1.22

1.04

1.9

1.8

g/l

9.8

10.6

0.96

641

(3005033) Fetal Nuchal fold Thickness US

419

4513

0.91

1.04

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

420

4521

0.91

1.03

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

169

1.47

1.02

1.8

1.9

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.25

1.02

1.2

1.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

244

1.38

1.02

6.0

7.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

495

1.26

1.02

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.04

1.01

1.0

1.9

pmol/l

5.0

9.3

—

(3045716) Anion gap in Serum or Plasma

145

1.50

1.01

3.0

2.9

mmol/l

8.1

9.5

1.68

114

(3004588) Protein electrophoresis panel - Serum or Plasma

164

1414

1.15

1.00

2.3

1.8

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

496

1.26

1.00

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

262

1.36

1.00

1.3

1.4

e6/l

30809.2

64148.0

0.50

181

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.72

0.99

1.5

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

305

1.33

0.99

1.1

1.2

98.8

95.4

0.25

134

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

1.67

0.98

2.5

3.0

ug/g

201.1

178.3

0.28

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.67

0.98

7.3

6.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

454

1.27

0.97

1.1

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

125

1059

1.17

0.97

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

238

1.37

0.97

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.96

0.0

1.1

—

0.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

491

1.25

0.95

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

172

1.44

0.95

1.3

1.4

e6/l

8319.0

3474.9

0.36

114

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

239

1.37

0.95

8.7

6.0

u/ml

59.5

192.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

492

1.25

0.94

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

156

1.46

0.94

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.75

0.93

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

387

1.28

0.93

1.4

1.8

umol/l

21.2

21.9

0.07

371

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

609

1.22

0.93

1.1

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

493

1.25

0.93

1.2

—

(3020650) Glucose [Presence] in Urine

190

1.41

0.92

1.5

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

120

1019

1.17

0.92

1.4

2.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

157

1.45

0.91

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1049

0.84

0.91

1.5

1.4

nmol/l

30.1

32.8

0.38

975

(3014148) Varicella zoster virus Ab [Titer] in Serum

161

1399

1.14

0.91

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

710

1.20

0.91

1.3

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

199

1.39

0.91

2.0

2.2

nmol/l

1.1

1.4

0.50

162

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

345

1.29

0.90

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

469

0.76

0.89

1.7

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.80

0.89

1.0

1.1

—

(3005570) Glucose [Moles/volume] in Urine

478

1.24

0.89

2.0

2.1

—

0.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

158

1.44

0.89

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

101

0.49

0.89

1.2

1.0

—

(3017732) Neutrophils [#/volume] in Blood

392

3582

1.09

0.89

2.6

2.1

e9/l

4.2

0.17

324

3000

(3032641) Amino acids panel - Urine

2.05

0.88

1.0

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

756

7904

0.94

0.88

2.0

2.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

142

1.47

0.88

1.0

1.1

—

137.1

—

(3014051) Protein [Presence] in Urine by Test strip

100

1162

0.85

0.88

1.7

1.9

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

209

1.38

0.87

1.0

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

204

1806

1.12

0.87

1.3

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

118

1.51

0.87

4.9

3.3

47.0

48.0

0.10

112

(3042111) Morphology [Interpretation] in Bone marrow Narrative

365

1.28

0.86

2.4

2.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

678

1.20

0.86

2.6

1.8

g/l

0.5

0.6

0.07

625

(3049717) Cytology report of Urine Cyto stain

669

1.20

0.86

2.4

2.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

322

1.29

0.85

1.2

u/l

71.3

92.0

0.65

220

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

220

1959

1.12

0.85

2.1

ug/l

8.0

6.7

0.31

200

1704

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

744

1.19

0.84

1.2

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4685

45788

1.04

0.84

9.5

7.7

ml/min/173m2

99.6

100.2

1.02

3557

35523

(3003694) ABO and Rh group [Type] in Blood

2180

22169

0.96

0.83

1.7

1.8

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.92

0.83

1.3

1.5

nmol/l

371.9

561.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.70

0.83

2.2

2.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

463

0.77

0.83

1.6

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

555

1.21

0.82

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

247

0.68

0.82

1.3

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

529

1.22

0.81

2.1

2.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

547

1.21

0.81

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

413

1.25

0.81

2.6

3.5

au/ml

133.0

115.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

316

1.29

0.81

1.1

93.9

95.2

0.14

137

(3021901) Oxygen saturation in Capillary blood

602

1.20

0.80

5.7

2.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

485

1.23

0.80

1.1

iu/ml

5.4

6.1

0.19

113

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

191

1695

1.12

0.80

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

162

1.41

0.80

1.2

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

191

1696

1.12

0.79

1.6

mmol/l

7.7

7.4

0.76

103

1021

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.68

0.79

7.8

4.9

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.69

0.79

1.9

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

549

1.21

0.79

1.5

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.0

—

(3008898) HLA-B27 [Presence]

326

2976

1.09

0.78

1.1

—

(4038314)

1.59

0.78

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.78

0.0

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

550

1.21

0.78

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

425

0.77

0.78

1.5

1.8

mg/l

48.7

24.4

—

123

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.80

0.78

1.3

pmol/l

18.0

14.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.51

0.77

1.0

1.4

—

(3014271) Vancomycin [Susceptibility]

0.50

0.77

3.8

2.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

240

2162

1.10

0.77

1.5

1.3

—

(3033799) Differential panel - Peritoneal fluid

1.71

0.75

1.8

2.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.71

0.75

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

165

1459

1.12

0.75

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.57

0.75

1.6

2.9

umol/l

1.2

0.00

(3009466) Valproate [Moles/volume] in Serum or Plasma

827

1.16

0.75

5.1

5.4

umol/l

404.1

375.3

1.24

724

(40768800) Prostate Pathology biopsy report

230

0.69

0.75

1.4

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

303

1.28

0.74

1.3

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

873

8260

1.05

0.74

2.3

2.4

u/l

7135.1

7104.7

0.01

320

3266

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

242

1.31

0.74

1.3

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.06

0.74

1.0

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

470

4366

1.07

0.74

1.3

miu/ml

240.4

233.0

0.16

216

2222

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

339

3112

1.08

0.73

1.5

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

118

1024

1.14

0.72

1.3

u/ml

1.2

4.1

—

(3045414) Leukocytes [Presence] in Urine

246

2228

1.10

0.72

1.6

1.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.98

0.72

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.59

0.71

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

421

1.22

0.71

1.2

1.4

pmol/l

72.7

51.9

0.43

119

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

277

2974

0.92

0.71

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

612

1.18

0.70

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

512

1.20

0.70

1.2

1.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.90

0.70

1.2

1.0

u/l

25.2

23.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.90

0.70

1.8

4.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

126

1102

1.13

0.70

1.2

1.1

—

(3017509) Phencyclidine [Presence] in Urine

168

0.65

0.70

2.0

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

549

1.19

0.69

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

549

1.19

0.69

1.5

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.83

0.68

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

459

0.80

0.68

1.3

1.6

mmol/l

5.6

5.8

0.30

387

(42529406) Shigella sp [Presence] in Stool by Culture

192

1726

1.10

0.67

1.2

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

561

5262

1.06

0.67

3.6

3.5

ug/l

2.2

1.8

0.37

517

4791

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.51

0.66

1.2

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

152

1.37

0.65

1.6

2.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

152

1.37

0.65

1.3

1.4

e6/l

31936.0

32008.4

0.00

(3021387) Prolactin [Units/volume] in Serum or Plasma

557

5228

1.06

0.65

1.6

mu/l

317.4

320.8

0.07

513

4675

(3014765) Yersinia sp identified in Stool by Organism specific culture

190

1712

1.10

0.64

1.2

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

563

1.18

0.64

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

148

1316

1.12

0.64

2.2

1.5

mmol/l

3.4

3.5

2.13

138

1238

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

545

1.18

0.64

3.5

4.0

u/ml

58.8

132.8

1.01

176

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

346

1.23

0.64

1.1

u/ml

17.7

15.8

—

(3029075) Extractable nuclear Ab panel - Serum

222

1.29

0.64

1.0

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

424

3950

1.07

0.64

2.3

2.0

nmol/l

10.2

0.02

373

3517

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

522

4895

1.06

0.64

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

196

1.31

0.63

1.9

1.5

u/l

4.5

4.2

0.05

103

(4146454)

233

0.72

0.63

3.2

2.8

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.71

0.63

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

258

1.27

0.62

1.3

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

145

1.37

0.62

1.6

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

145

1.37

0.62

1.6

2.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

145

1593

0.90

0.62

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

438

4594

0.94

0.62

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

303

1.24

0.61

1.5

1.6

nmol/l

1.4

2.2

0.58

242

(3009542) Hematocrit [Volume Fraction] of Blood

5652

55561

1.04

0.61

13.6

10.2

40.1

40.2

0.50

4782

46443

(3044007) Cell count panel - Peritoneal fluid

1.58

0.60

1.4

2.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.65

0.60

1.2

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

304

1.24

0.60

1.7

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

762

0.86

0.60

1.1

—

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

147

1314

1.11

0.59

2.4

1.6

e6/l

23.8

18.7

0.18

113

1016

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

287

1.24

0.59

2.0

1.5

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.59

0.0

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

541

1.17

0.59

1.4

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

208

1.29

0.58

1.2

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

182

1.31

0.57

1.5

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

182

1.31

0.57

1.5

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

182

1.31

0.57

1.5

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

182

1.31

0.57

1.5

2.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

174

1.31

0.56

1.0

u/ml

0.0

0.2

—

109

(4198724)

756

0.86

0.56

1.7

2.7

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

140

1.34

0.55

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

140

1.34

0.55

1.6

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

138

1507

0.90

0.55

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1007

0.88

0.55

3.5

2.9

mg/l

33.0

23.6

1.07

617

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.51

0.54

1.1

—

43.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

491

1.17

0.54

2.1

1.6

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

146

1315

1.10

0.53

2.5

1.7

e6/l

444.2

3703.1

0.61

120

1064

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

229

1.25

0.53

4.4

4.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

124

1.36

0.53

1.3

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

353

3297

1.06

0.52

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

1.52

0.52

1.3

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

473

0.84

0.50

1.2

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

294

1.21

0.50

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

294

1.21

0.50

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

294

1.21

0.50

1.4

1.7

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

662

1.14

0.50

4.1

3.6

u/ml

17.6

54.7

0.62

560

(40765089) Chromosome analysis panel - Blood by G-banded

568

0.85

0.50

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

139

1255

1.10

0.49

2.4

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

100

1.39

0.49

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

100

1.39

0.49

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

433

4079

1.05

0.49

3.3

3.2

21.7

21.1

0.27

146

1425

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

636

1.14

0.48

2.3

1.7

g/l

0.0

0.63

600

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

170

1.28

0.48

2.6

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

350

1.19

0.48

2.0

3.5

umol/l

112.5

174.6

0.72

189

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

135

1.32

0.48

1.2

1.3

—

1101.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

139

1503

0.91

0.48

1.1

—

(3019225) pH of Specimen

350

3282

1.06

0.47

3.6

3.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

266

2473

1.07

0.47

2.3

2.2

u/ml

33.1

32.7

0.02

254

2385

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

300

2802

1.06

0.46

4.3

3.3

mmol/l

1.2

0.55

260

2400

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

270

2516

1.06

0.45

1.1

u/ml

2.5

2.1

0.22

134

1192

(3020356) Listeria sp identified in Specimen by Organism specific culture

119

0.67

0.45

1.3

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

159

1703

0.92

0.45

1.5

1.6

—

(3047189) Immunofixation for 24 hour Urine

1.46

0.45

1.3

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

163

1492

1.08

0.44

2.2

1.6

mg/l

398.1

434.4

0.49

154

1420

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

725

1.12

0.44

1.6

1.7

—

(3006653) Thiamine [Moles/volume] in Blood

208

1.24

0.44

1.2

1.4

nmol/l

134.1

133.7

0.01

208

(3003327) Ova and parasites identified in Stool by Light microscopy

278

2597

1.06

0.44

1.6

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

537

5106

1.04

0.43

1.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

120

1.32

0.43

1.1

u/ml

0.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2682

26169

1.02

0.43

2.2

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.60

0.42

1.8

1.4

mg/l

1.5

1.3

—

(3011985) Renin [Units/volume] in Plasma

550

1.14

0.42

2.0

1.8

mu/l

107.2

58.7

0.53

505

(46235168) Fasting glucose [Moles/volume] in Blood

1.44

0.42

1.0

1.1

mmol/l

10.0

8.0

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.63

0.42

1.5

1.8

mg/l

1.4

1.5

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

319

1.18

0.42

2.8

2.7

51.8

53.5

0.17

207

(3022475) Manganese [Moles/volume] in Blood

1.55

0.42

1.0

1.2

—

(4211845)

292

1.19

0.41

1.7

2.3

—

(40768441) Liver Pathology biopsy report

329

1.17

0.41

2.6

1.4

—

(3017569) Oxygen content in Arterial blood

104

1.33

0.40

2.1

2.5

—

(3044316) Mercury [Moles/volume] in Urine

0.00

0.40

0.0

1.5

—

3.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

422

1.15

0.40

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

193

1.23

0.40

1.2

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

193

1.23

0.40

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

584

5576

1.04

0.40

2.4

2.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

612

5849

1.04

0.40

1.2

1.3

iu/ml

142.5

143.1

0.01

239

2156

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.46

0.40

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.46

0.40

14.2

3.8

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.40

0.0

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

460

1.14

0.39

1.2

1.1

ratio

1.0

1.1

0.13

176

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

131

1.29

0.39

1.1

1.0

u/ml

0.0

2.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

131

1.29

0.39

1.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

102

0.68

0.39

3.1

2.6

—

(3013862) HLA-DP [Type]

0.00

0.39

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.39

0.0

1.0

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

7.9

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.39

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.39

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.39

0.0

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

276

1.18

0.38

1.1

nmol/l

0.1

4.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.35

0.38

1.5

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

231

1.20

0.38

1.1

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

212

0.79

0.38

1.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.38

0.38

3.0

4.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.38

0.38

4.8

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

287

2987

0.95

0.37

1.3

1.4

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

106

1.31

0.37

1.1

1.0

u/ml

7.5

27.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

676

0.89

0.36

2.6

ug/min

91.5

105.5

0.16

447

(3015183) Erythrocyte sedimentation rate

389

1.15

0.36

1.3

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

389

1.15

0.36

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

269

1.18

0.36

1.3

1.6

39.0

41.0

0.11

178

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

233

2183

1.06

0.36

1.4

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

169

1.23

0.36

2.8

3.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

283

2667

1.05

0.36

1.3

ug/l

4.0

0.08

273

2558

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

624

1.11

0.35

1.6

1.8

g/l

39.2

38.9

0.15

564

(3013512) EKG study

940

9075

1.03

0.35

2.8

2.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

514

5268

0.96

0.35

1.8

—

(40768795) Lymph node Pathology biopsy report

335

1.15

0.34

1.3

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

104

948

1.09

0.34

2.6

2.1

g/l

131.8

132.7

0.17

755

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.35

0.34

1.0

1.1

—

(4094501)

672

0.90

0.34

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

132

0.75

0.34

1.2

1.1

—

(40768806) Pleura Pathology biopsy report

154

0.77

0.34

1.5

1.4

—

(3023410) Appearance of Cerebral spinal fluid

674

1.10

0.34

3.4

2.0

—

(3006462) Nitrate [Presence] in Urine

262

1.17

0.33

1.8

2.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

234

2199

1.06

0.33

1.1

u/ml

2.3

3.1

0.46

635

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

364

1.14

0.33

1.3

1.7

50.6

49.8

0.05

248

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

153

1.23

0.33

2.7

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

393

1.13

0.32

1.1

—

(3027944) Amphetamines [Presence] in Urine

720

6936

1.03

0.32

2.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

407

4180

0.96

0.32

1.4

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

172

1.21

0.31

2.0

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

154

1.22

0.31

2.8

1.7

—

(40758292) HTLV I+II Ab panel - Serum

130

0.76

0.31

1.7

1.2

—

(3042631) Mycobacterium sp identified in Specimen

265

1.16

0.30

2.3

3.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

155

1.21

0.30

2.9

1.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.26

0.29

1.1

1.0

—

(40768443) Skin Pathology biopsy report

183

1717

1.06

0.29

1.1

1.2

—

(3003181) Sodium [Moles/volume] in Urine

444

1.12

0.29

2.1

mmol/l

70.4

73.7

0.19

371

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

426

1.12

0.28

1.1

u/l

1.0

0.14

180

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.32

0.28

4.8

5.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

138

1.22

0.28

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

193

1.18

0.28

1.2

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

230

1.16

0.28

1.9

2.1

g/24h

2.5

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

235

2432

0.95

0.28

1.6

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.26

0.27

1.6

1.2

—

(44813793)

620

0.91

0.27

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

181

0.82

0.27

1.3

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.22

0.27

1.3

1.1

—

2.0

—

(40767503) Oxygen content in Capillary blood by calculation

783

0.92

0.26

3.1

2.3

17.7

17.4

0.25

372

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

112

1.24

0.26

6.4

5.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

103

1.25

0.26

1.5

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

172

1619

1.05

0.26

1.1

u/ml

10.2

7.3

0.43

777

(3016330) Potassium [Moles/time] in 24 hour Urine

0.70

0.26

1.2

1.4

—

90.9

—

(3019174) dRVVT (LA screen)

0.68

0.26

1.4

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

338

0.88

0.26

1.9

2.0

—

(3012441) Differential panel - Pleural fluid

158

1.19

0.26

1.3

1.4

—

(3002256) Pathology report gross observation

545

5255

1.03

0.25

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

140

1.20

0.25

5.1

2.8

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

364

1.12

0.25

1.3

1.2

u/ml

2.7

8.6

—

(3043409) Potassium [Moles/volume] in Arterial blood

801

0.93

0.25

7.0

3.8

mmol/l

3.8

0.05

741

(3029396) Erythrocyte agglutination [Presence] in Blood

575

0.91

0.25

3.5

3.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

136

0.80

0.24

2.2

2.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.29

0.24

7.0

6.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

263

0.87

0.24

2.8

2.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1205

11741

1.02

0.24

2.5

2.0

—

(3004616) Nuclear Ab [Presence] in Serum

517

1.09

0.24

1.5

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

147

1384

1.05

0.23

1.0

1.1

u/ml

0.3

0.4

0.19

337

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

213

2024

1.04

0.23

1.5

1.6

iu/ml

1.0

0.2

0.39

379

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.30

0.23

11.0

8.2

—

(40768793) Breast Pathology biopsy report

874

1.07

0.22

1.3

—

(3025941) Bacteria identified in Stool by Culture

379

3645

1.03

0.22

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

1.24

0.22

1.0

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

635

1.08

0.22

1.1

u/ml

0.3

1.4

0.95

122

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

1.21

0.21

1.0

u/ml

13.5

16.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.21

0.21

4.8

1.3

—

(21494434) Karyotype in Bone marrow

236

1.13

0.21

1.3

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.21

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.21

0.0

1.2

—

0.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

196.7

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.24

0.21

1.3

1.7

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.20

0.0

1.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.20

0.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

493

4995

0.98

0.20

3.9

2.8

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

125

1.19

0.20

1.2

1.3

u/l

757.1

390.8

0.40

119

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.20

0.0

2.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.20

0.0

1.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.20

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.20

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.20

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.20

0.0

1.0

—

3.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.20

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.20

0.0

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

332

1.10

0.20

1.1

u/ml

38.0

7.5

0.64

247

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

375

3615

1.03

0.20

2.3

au/ml

19.6

19.7

0.01

273

(3014133) Dog dander IgE Ab [Units/volume] in Serum

185

1762

1.04

0.19

1.1

u/ml

6.3

5.1

0.13

801

(3016018) Differential panel - Cerebral spinal fluid

658

1.07

0.19

2.3

1.7

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.19

0.19

1.5

2.3

—

(3022621) pH of Urine by Test strip

316

3218

0.97

0.19

2.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1.22

0.19

1.3

1.2

u/l

24.6

13.8

0.30

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

117

1.18

0.18

1.2

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

963

9396

1.02

0.18

1.8

1.7

1.3

1.4

0.34

893

8537

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

516

1.07

0.18

1.4

1.5

pmol/l

475.2

385.2

0.55

424

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

568

5514

1.02

0.18

1.5

1.6

—

(3000012) Reticulocyte production index

164

1.15

0.18

1.3

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

1.22

0.18

2.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.16

0.17

1.0

4.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

157

1615

0.96

0.17

2.2

2.1

iu/l

4.4

3.9

0.24

664

(3013293) Extractable nuclear Ab [Presence] in Serum

1.22

0.17

1.7

1.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

250

1.11

0.17

1.5

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

239

2296

1.03

0.17

1.7

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

403

1.08

0.17

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

140

0.85

0.16

1.0

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

156

1.14

0.16

6.3

2.3

mmol/l

0.8

2.0

2.32

121

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

308

1.09

0.16

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

693

0.94

0.16

1.1

—

(40761536) Microorganisms panel - Urine sediment

527

5312

0.98

0.16

3.5

3.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

293

2974

0.97

0.16

2.4

ug/l

0.6

0.7

0.09

158

1576

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2105

20681

1.01

0.15

1.8

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.75

0.15

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

427

0.93

0.15

1.4

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

148

1.14

0.15

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

293

2970

0.98

0.15

1.4

1.5

mg/l

4.3

4.0

0.12

192

1915

(3041672) Baker's yeast Ab [Presence] in Serum

0.81

0.14

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

127

0.86

0.14

1.5

ug/l

9.4

8.5

0.20

127

(3008295) Osmolality of Serum or Plasma

455

0.94

0.14

2.7

2.1

mosm/kgh2o

287.1

287.8

0.10

358

(3020874) Milk IgE Ab [Units/volume] in Serum

708

1.05

0.13

1.1

u/ml

2.5

3.2

0.17

277

(3021788) Differential panel - Synovial fluid

544

1.06

0.13

1.4

1.6

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.18

0.12

1.1

1.0

u/ml

0.1

0.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

265

1.08

0.12

1.8

1.6

—

(3027008) Opiates [Presence] in Urine

723

7071

1.01

0.12

2.3

2.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

233

2254

1.02

0.12

1.1

u/ml

7.4

7.8

0.13

150

1361

(3019832) Treponema pallidum Ab [Presence] in Serum

1890

18831

0.99

0.12

1.8

—

(3002619) Bacteria identified in Specimen by Culture

115

0.86

0.12

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

668

6531

1.01

0.12

2.3

2.1

—

(40761535) Cells panel - Urine sediment

314

3168

0.98

0.12

3.5

3.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

543

0.95

0.12

1.3

—

31.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

187

0.90

0.11

1.1

1.0

u/ml

0.0

1.5

—

108

(3028300) Cannabinoids [Presence] in Urine

724

7088

1.01

0.11

2.3

2.1

—

(44806071)

1.16

0.11

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

888

1.04

0.11

1.4

1.3

umol/l

6.4

0.03

828

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

142

1.12

0.11

1.4

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

684

1.04

0.10

1.0

1.1

u/ml

1.7

6.7

0.84

233

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

248

1.08

0.10

2.4

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

206

0.91

0.10

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.15

0.10

1.0

1.1

—

(3011436) Histone Ab [Units/volume] in Serum

1.15

0.10

1.3

1.1

u/ml

—

9.8

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

175

0.90

0.10

1.0

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.15

0.10

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.12

0.10

1.6

1.4

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.10

0.09

1.8

2.8

pmol/l

33.7

51.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

113

0.88

0.09

1.2

—

(3042517) Benzodiazepines panel - Urine

172

1.09

0.09

3.5

2.4

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.15

0.09

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

1.15

0.09

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.15

0.09

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.15

0.09

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

121

1165

1.03

0.09

1.7

1.8

pmol/l

165.7

172.3

0.27

114

1108

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.05

0.09

1.8

3.7

mg/l

0.6

1.9

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

211

1.08

0.09

1.2

100.0

100.9

0.06

196

(44816559) Phosphatidylethanol [Mass/volume] in Blood

165

1598

1.02

0.09

1.2

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.12

0.09

2.2

1.9

u/field

1.5

0.9

—

(3001556) Androgen free Index in Serum or Plasma

204

0.92

0.08

1.0

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

532

1.04

0.08

2.6

2.7

mmol/l

1.3

1.4

0.77

516

(3045683) HLA typing for celiac disease panel - Blood or Tissue

537

0.96

0.08

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.06

0.08

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

607

0.96

0.08

1.4

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.80

0.08

1.0

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

416

1.05

0.08

1.0

u/ml

17.1

8.3

—

(3006598) pH of Arterial cord blood

1.10

0.08

1.0

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

183

0.92

0.08

1.1

1.0

u/ml

38.3

3.3

—

101

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.07

0.08

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1006

0.97

0.07

1.1

iu/ml

53.1

1349.8

0.81

316

(3007463) Buprenorphine [Presence] in Urine

0.81

0.07

11.3

5.1

—

(3035880) pH of Pleural fluid

1.03

0.07

1.1

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

568

5573

1.01

0.07

2.0

1.9

—

(4133840)

165

1.08

0.07

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.13

0.07

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

311

1.05

0.07

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

516

1.04

0.06

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

220

2146

1.02

0.06

1.1

u/ml

0.9

1.5

1.74

122

1090

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

101

0.88

0.06

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

715

7029

1.01

0.06

2.3

2.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

127

1.09

0.06

1.7

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

135

1361

0.98

0.06

1.3

1.4

u/l

12.3

13.7

0.40

123

1188

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

194

1893

1.01

0.06

1.7

1.6

nmol/l

0.4

0.01

154

1597

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

170

0.93

0.05

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

200

0.94

0.05

1.2

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

196

1.06

0.05

3.2

2.9

nmol/l

0.7

0.9

1.15

150

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

378

3711

1.01

0.05

2.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

889

0.98

0.05

3.6

2.7

nmol/l

0.9

0.8

0.41

756

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

139

0.93

0.05

1.2

2.0

nmol/l

3.7

3.9

0.04

131

(21494755) Public health laboratory ask at order entry panel

821

8166

0.99

0.04

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

189

0.94

0.04

1.3

2.4

—

28.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

491

1.03

0.04

3.7

5.2

mmol/l

6.7

6.6

0.07

383

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

369

0.97

0.04

1.3

1.1

—

(4027681)

550

1.03

0.04

1.3

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

319

0.96

0.04

5.2

6.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

319

0.96

0.04

2.6

3.1

—

(3020891) Body temperature

114

1146

0.98

0.04

6.7

4.8

—

(1616796) Gas panel - Central venous blood

915

1.02

0.04

5.4

3.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

247

1.04

0.03

1.6

u/field

2.4

3.7

0.40

172

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

556

0.98

0.03

1.4

74.3

73.4

0.26

525

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

1.08

0.03

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

121

1186

1.01

0.02

1.6

mmol/l

6.9

6.4

0.95

821

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

673

0.99

0.02

1.1

1.2

mg/l

26.0

38.0

4.30

554

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

338

1.03

0.02

1.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

161

1.05

0.02

1.1

1.0

u/ml

0.0

0.6

—

(3004451) EKG impression Narrative

102

1.07

0.02

1.0

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

576

1.01

0.01

1.9

1.5

promille

1.4

1.3

0.15

436

(3035933) Granulocytes/100 leukocytes in Blood

300

1.02

0.01

1.5

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

720

0.99

0.01

4.5

2.8

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

125

0.95

0.01

1.2

1.1

u/ml

7.1

12.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.06

0.01

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

105

0.94

0.01

1.1

1.0

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

541

0.99

0.00

1.4

mu/l

450.3

497.4

0.31

510

(3032868) Hemoglobin electrophoresis panel in Blood

1.00

0.00

1.7

1.6

—

(40765096) Chromosome analysis panel by Banding

1.00

0.00

1.5

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

165

1.02

0.00

2.9

2.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

641

1.00

0.00

1.1

—

(4281824)

321

0.99

0.00

1.2

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

477

1.00

0.00

2.9

2.7

mmol/l

6.6

6.9

0.32

468

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

649

1.01

0.00

1.1

mg/l

176.6

214.4

2.13

564

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

819

1.00

0.00

1.4

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

109

1.00

0.00

9.0

3.8

—

(3044927) Protein electrophoresis panel - Urine

172

0.98

0.00

1.1

—

(3036603) Volume of Urine

236

1.01

0.00

1.7

1.5

1694.3

2167.1

—

(3030313) Adrenal Ab [Titer] in Serum

128

1.01

0.00

1.1

1.2

—

(3016038) Potassium [Moles/volume] in Urine

224

1.02

0.00

2.2

2.5

mmol/l

35.2

36.4

0.09

215

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

471

1.01

0.00

1.1

1.3

mmol/l

1.9

1.7

0.20

438

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

205

1.01

0.00

1.0

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

257

2548

1.00

0.00

2.8

2.4

umol/l

6.0

5.3

0.26

203

1899

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

274

1.01

0.00

2.8

2.0

u/field

2.1

2.2

0.09

145

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

274

1.01

0.00

2.0

1.6

—

(3011897) Casein IgE Ab [Units/volume] in Serum

258

1.00

0.00

1.2

1.3

u/ml

9.6

9.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

162

0.98

0.00

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

314

3104

1.00

0.00

3.3

2.7

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.93

0.00

1.0

1.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.6

—

672.3

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.91

0.00

1.2

1.1

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.4

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

3.6

—

(3011048) Pyruvate [Moles/volume] in Blood

0.99

0.00

1.1

1.5

umol/l

80.7

84.6

—

(3018487) Sunflower Seed IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

1.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.2

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.0

1.0

—

12.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.1

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

1.5

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

2.6

—

9.3

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.0

—

1258.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.96

0.00

1.0

1.1

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

1.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.99

0.00

1.2

1.1

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.0

1.2

—

177.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.00

0.00

1.0

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.6

—

10.1

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

-0.00

0.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_ERUPTION and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_ERUPTION	1.532 [1.23, 1.91]	< 0.001
Birth year	0.997 [0.99, 1.01]	0.428

During the follow-up period (1.1.1998 — 31.12.2019), 429 out of 41748 females with K11_ERUPTION died.

Males

Parameter	HR [95% CI]	p-value
K11_ERUPTION	1.505 [1.21, 1.87]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 734 out of 31671 males with K11_ERUPTION died.

Mortality risk

Mortality risk for people of age

years, who have K11_ERUPTION.

N-year risk	Females	Males
1	0.201%	0.285%
5	0.977%	1.596%
10	2.308%	4.115%
15	4.4%	7.761%
20	7.646%	12.752%

Relationships between endpoints

↥

Index endpoint: K11_ERUPTION – Tooth eruption problems

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Tooth eruption problems

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints